Skip to main content
Log in

Sofosbuvir regimens cost saving for HIV/HCV co-infection in Italy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. hepatitis C virus

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sofosbuvir regimens cost saving for HIV/HCV co-infection in Italy. PharmacoEcon Outcomes News 744, 28 (2016). https://doi.org/10.1007/s40274-016-2732-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2732-y

Navigation